On December 10, Geelong Hu announced that Wuhan Hiteck Biological Pharma (300683.SZ) disclosed that the Board of Directors has drafted the profit distribution plan for the first half of 2024 under the premise of adhering to the profit distribution principles and ensuring the normal Operation and long-term development of the company. Based on a total share capital of 130,894,391 shares as of the disclosure date of this announcement, it is proposed to distribute a cash dividend of 1.30 yuan (tax included) for every 10 shares to all Shareholders, totaling a cash dividend distribution of 17,016,270.83 yuan (tax included). This profit distribution does not increase the share capital, nor is there a bonus issue.